Suppr超能文献

肝细胞腺瘤:我们现在在哪里?

Hepatocellular adenoma: Where are we now?

机构信息

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, United States.

出版信息

World J Gastroenterol. 2022 Apr 14;28(14):1384-1393. doi: 10.3748/wjg.v28.i14.1384.

Abstract

Hepatocellular adenoma (HCA) is a benign hepatocellular neoplasm, commonly occurs in young women with a history of oral contraceptive use. Complications including hemorrhage and malignant transformation necessitate the need for a thorough understanding of the underlying molecular signatures in this entity. Recent molecular studies have significantly expanded our knowledge of HCAs. The well-developed phenotype-genotype classification system improves clinical management through identifying "high risk" subtype of HCAs. In this article, we attempt to provide updated information on clinical, pathologic and molecular features of each subtype of HCAs.

摘要

肝细胞腺瘤(HCA)是一种良性肝细胞肿瘤,常见于有口服避孕药使用史的年轻女性。出血和恶性转化等并发症需要对该肿瘤的潜在分子特征有深入了解。最近的分子研究显著扩展了我们对 HCAs 的认识。完善的表型-基因型分类系统通过识别 HCA 的“高危”亚型来改善临床管理。本文尝试提供关于每种 HCA 亚型的临床、病理和分子特征的最新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53d/9048476/eb0055ce84a1/WJG-28-1384-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验